35 Spam-Free Article(s) Found
Article Searches
Bristol Myers (BMY) Clinches FDA Nod for MS Drug Zeposia http://www.zacks.com/stock/news/838749/bristol-myers-bmy-clinches-fda-nod-for-ms-drug-zeposia?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-838749 Mar 27, 2020 - The FDA approves Bristol Myers' (BMY) Zeposia for the treatment of adults with relapsing forms of multiple sclerosis.
AstraZeneca's Lokelma Gets Approval in Japan for Hyperkalaemia http://www.zacks.com/stock/news/837022/astrazenecas-lokelma-gets-approval-in-japan-for-hyperkalaemia?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-837022 Mar 26, 2020 - The Japanese regulatory body nods to AstraZeneca's (AZN) Lokelma for addressing patients with hyperkalaemia. The company collaborates with Silence Therapeutics for siRNA therapeutics.
Pfizer's Eczema Drug Eucrisa Gets FDA Approval for Infants http://www.zacks.com/stock/news/834155/pfizers-eczema-drug-eucrisa-gets-fda-approval-for-infants?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-834155 Mar 25, 2020 - Pfizer (PFE) gets FDA approval for label expansion of Eucrisa to include children aged three months to two years with mild-to-moderate atopic dermatitis or eczema.
3 Reasons Pharma Stocks Are a Buy Right Now https://www.fool.com/investing/2020/03/25/3-reasons-pharma-stocks-are-a-buy-right-now.aspx?source=iedfolrf0000001 Mar 25, 2020 - The coronavirus outbreak has made shares of top drugmakers more attractive than they've been in a quite a while.
Company News for Mar 18, 2020 http://www.zacks.com/stock/news/820513/company-news-for-mar-18-2020?cid=CS-ZC--corporate_summary-820513 Mar 18, 2020 - Companies In The News Are: PFE, BNTX, REGN, DNKN. TMO.

Pages: 1234

<<<Page 4